205 related articles for article (PubMed ID: 35999080)
1. A human model of arteriovenous malformation (AVM)-on-a-chip reproduces key disease hallmarks and enables drug testing in perfused human vessel networks.
Soon K; Li M; Wu R; Zhou A; Khosraviani N; Turner WD; Wythe JD; Fish JE; Nunes SS
Biomaterials; 2022 Sep; 288():121729. PubMed ID: 35999080
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
[TBL] [Abstract][Full Text] [Related]
3. Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.
Fish JE; Flores Suarez CP; Boudreau E; Herman AM; Gutierrez MC; Gustafson D; DiStefano PV; Cui M; Chen Z; De Ruiz KB; Schexnayder TS; Ward CS; Radovanovic I; Wythe JD
Circ Res; 2020 Aug; 127(6):727-743. PubMed ID: 32552404
[TBL] [Abstract][Full Text] [Related]
4. Endothelial MAP2K1 mutations in arteriovenous malformation activate the RAS/MAPK pathway.
Smits PJ; Konczyk DJ; Sudduth CL; Goss JA; Greene AK
Biochem Biophys Res Commun; 2020 Aug; 529(2):450-454. PubMed ID: 32703450
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of arteriovenous malformations in the absence of endoglin.
Mahmoud M; Allinson KR; Zhai Z; Oakenfull R; Ghandi P; Adams RH; Fruttiger M; Arthur HM
Circ Res; 2010 Apr; 106(8):1425-33. PubMed ID: 20224041
[TBL] [Abstract][Full Text] [Related]
6. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
[TBL] [Abstract][Full Text] [Related]
7. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Vetiska S; Bonilla X; Boudreau E; Jauhiainen S; Rezai Jahromi B; Khyzha N; DiStefano PV; Suutarinen S; Kiehl TR; Mendes Pereira V; Herman AM; Krings T; Andrade-Barazarte H; Tung T; Valiante T; Zadeh G; Tymianski M; Rauramaa T; Ylä-Herttuala S; Wythe JD; Antonarakis SE; Frösen J; Fish JE; Radovanovic I
N Engl J Med; 2018 Jan; 378(3):250-261. PubMed ID: 29298116
[TBL] [Abstract][Full Text] [Related]
8. Arteriovenous malformation associated with a HRAS mutation.
Konczyk DJ; Goss JA; Smits PJ; Huang AY; Al-Ibraheemi A; Sudduth CL; Warman ML; Greene AK
Hum Genet; 2019 Dec; 138(11-12):1419-1421. PubMed ID: 31637524
[TBL] [Abstract][Full Text] [Related]
9. VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.
Han C; Choe SW; Kim YH; Acharya AP; Keselowsky BG; Sorg BS; Lee YJ; Oh SP
Angiogenesis; 2014 Oct; 17(4):823-830. PubMed ID: 24957885
[TBL] [Abstract][Full Text] [Related]
10. Constitutively active Notch4 receptor elicits brain arteriovenous malformations through enlargement of capillary-like vessels.
Murphy PA; Kim TN; Huang L; Nielsen CM; Lawton MT; Adams RH; Schaffer CB; Wang RA
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):18007-12. PubMed ID: 25468970
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations in intracranial arteriovenous malformations.
Goss JA; Huang AY; Smith E; Konczyk DJ; Smits PJ; Sudduth CL; Stapleton C; Patel A; Alexandrescu S; Warman ML; Greene AK
PLoS One; 2019; 14(12):e0226852. PubMed ID: 31891627
[TBL] [Abstract][Full Text] [Related]
12. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.
Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM
Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812
[TBL] [Abstract][Full Text] [Related]
13. Oscillatory shear stress promotes angiogenic effects in arteriovenous malformations endothelial cells.
Ryu JY; Kim YH; Lee JS; Lee JW; Oh EJ; Kim HM; Lee SJ; Lee J; Lee SY; Huh S; Kim JY; Im S; Chung HY
Mol Med; 2021 Mar; 27(1):31. PubMed ID: 33789563
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumour 1-associating protein inhibits endothelial cell angiogenesis by m6A-dependent epigenetic silencing of desmoplakin in brain arteriovenous malformation.
Wang LJ; Xue Y; Li H; Huo R; Yan Z; Wang J; Xu H; Wang J; Cao Y; Zhao JZ
J Cell Mol Med; 2020 May; 24(9):4981-4991. PubMed ID: 32281240
[TBL] [Abstract][Full Text] [Related]
15. Activating KRAS mutations in arteriovenous malformations of the brain: frequency and clinicopathologic correlation.
Priemer DS; Vortmeyer AO; Zhang S; Chang HY; Curless KL; Cheng L
Hum Pathol; 2019 Jul; 89():33-39. PubMed ID: 31026472
[TBL] [Abstract][Full Text] [Related]
16. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
[TBL] [Abstract][Full Text] [Related]
17. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM
Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088
[TBL] [Abstract][Full Text] [Related]
18. Somatic second hit mutation of RASA1 in vascular endothelial cells in capillary malformation-arteriovenous malformation.
Lapinski PE; Doosti A; Salato V; North P; Burrows PE; King PD
Eur J Med Genet; 2018 Jan; 61(1):11-16. PubMed ID: 29024832
[TBL] [Abstract][Full Text] [Related]
19. rasa1-related arteriovenous malformation is driven by aberrant venous signalling.
Greysson-Wong J; Rode R; Ryu JR; Chan JL; Davari P; Rinker KD; Childs SJ
Development; 2023 Sep; 150(18):. PubMed ID: 37708300
[TBL] [Abstract][Full Text] [Related]
20. Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.
Amyere M; Revencu N; Helaers R; Pairet E; Baselga E; Cordisco M; Chung W; Dubois J; Lacour JP; Martorell L; Mazereeuw-Hautier J; Pyeritz RE; Amor DJ; Bisdorff A; Blei F; Bombei H; Dompmartin A; Brooks D; Dupont J; González-Enseñat MA; Frieden I; Gérard M; Kvarnung M; Hanson-Kahn AK; Hudgins L; Léauté-Labrèze C; McCuaig C; Metry D; Parent P; Paul C; Petit F; Phan A; Quere I; Salhi A; Turner A; Vabres P; Vicente A; Wargon O; Watanabe S; Weibel L; Wilson A; Willing M; Mulliken JB; Boon LM; Vikkula M
Circulation; 2017 Sep; 136(11):1037-1048. PubMed ID: 28687708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
